Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00439374 · ClinicalTrials.gov registry record · Phase 3
RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix
A Phase 3 study, sponsored by The George Washington University Biostatistics Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 657
- Enrollment target
NCT00439374 is a Phase 3 study that was terminated before completion, run by The George Washington University Biostatistics Center. The registered enrollment target is 657 participants.
The verdict
NCT00439374, a Phase 3 study, was terminated before completion, sponsored by The George Washington University Biostatistics Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 657 participants
- Enrollment target
Study Summary
The purpose of this study is to see if giving progesterone medication to pregnant women, who have never delivered a baby after 19 weeks of pregnancy and who have a short cervix, lowers the risk of early delivery and improves the health of their baby.
Interventions
- OTHER Placebo Oil
- DRUG 17 alpha-hydroxyprogesterone caproate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 657 participants |
| Start Date | 2007-04 |
| Est. Completion | 2011-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00439374
The ClinicalTrials.gov registry entry for NCT00439374 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 657 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The George Washington University Biostatistics Center, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Oil is the first listed.
NCT00439374 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00439374 about?
NCT00439374 is a clinical study titled "RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix". The purpose of this study is to see if giving progesterone medication to pregnant women, who have never delivered a baby after 19 weeks of pregnancy and who have a short cervix, lowers the risk of early delivery and improves the health of their baby.
What is the current status of trial NCT00439374?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 657 participants. The study started on 2007-04. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00439374?
The interventions under investigation include: Placebo Oil (OTHER), 17 alpha-hydroxyprogesterone caproate (DRUG).
Who is sponsoring clinical trial NCT00439374?
This trial is sponsored by The George Washington University Biostatistics Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.